Elevated chromogranin A (CgA) serum levels in the patients with advanced pancreatic cancer

scientific article published on 07 March 2008

Elevated chromogranin A (CgA) serum levels in the patients with advanced pancreatic cancer is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1016/J.ARCHGER.2008.01.014
P698PubMed publication ID18329114

P50authorAndrea CavallaroQ30512636
Michele MalaguarneraQ80688977
P2093author name stringMassimo Motta
Massimiliano Beretta
Helga Lipari
Lisa Cammalleri
Erika Cristaldi
Valentina Colonna
Innocenza Alessandria
Salvatore Luca
Alessandra Capici
P433issue2
P921main subjectpancreatic cancerQ212961
P304page(s)213-217
P577publication date2008-03-07
P1433published inArchives of Gerontology and GeriatricsQ15749513
P1476titleElevated chromogranin A (CgA) serum levels in the patients with advanced pancreatic cancer
P478volume48

Reverse relations

cites work (P2860)
Q38931272Advances in the diagnosis and treatment of pancreatic neuroendocrine neoplasms in Japan
Q34036884Chromogranin A is a reliable serum diagnostic biomarker for pancreatic neuroendocrine tumors but not for insulinomas
Q34485940Elevated serum levels of Chromogranin A in hepatocellular carcinoma
Q46152235Is ⁶⁸Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour?
Q34628852Markers of bile duct tumors
Q89657745Pancreatic Fibrosis and Chronic Pancreatitis: Mini-Review of Non-Histologic Diagnosis for Clinical Applications
Q35713515Serum chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumors
Q92422983Specific and Non-Specific Biomarkers in Neuroendocrine Gastroenteropancreatic Tumors
Q51089461Utility of chromogranin B compared with chromogranin A as a biomarker in Japanese patients with pancreatic neuroendocrine tumors.

Search more.